The PRN & Moderna agreement gives Members on-invoice savings on both the COVID-19 and RSV vaccine.
Click here to inquire about current pricing & discount details.
Messenger RNA is not new technology, but Moderna is discovering new ways to use it to treat and prevent illnesses and diseases. Since Moderna’s founding in 2010, they have worked to build the industry's leading mRNA technology platform. As part of the PRN Group Purchasing Program, Moderna’s COVID-19 and RSV Vaccines must be purchased exclusively in lieu of equivalent vaccines from any other vendors.
Visit Moderna Atlas for navigating mRNA science with medical information, educational resources, and interactive data dashboard relevant to your patients and practice.
Member Benefits:
Members may have access to the following discounts*: •
5% Pre-Book discount
2% discount for ordering direct and paying within 60 days
Members may also be eligible to earn additional 2% on-invoice discount for Both VaxNeuvance and Moderna COVID-19 Vaccine Formulation for 2023 via the Merck and Moderna Special Offer (“MMSO”).
